| Literature DB >> 34974652 |
Byung Chul Yu1, Miyeun Han2, Gang-Jee Ko3, Jae Won Yang4, Soon Hyo Kwon5, Sungjin Chung6, Yu Ah Hong7, Young Youl Hyun8, Jang-Hee Cho9, Kyung Don Yoo10, Eunjin Bae11, Woo Yeong Park12, In O Sun13, Dongryul Kim14, Hyunsuk Kim15, Won Min Hwang16, Sang Heon Song17, Sung Joon Shin18.
Abstract
BACKGROUND: Evidence of the ethical appropriateness and clinical benefits of shared decision-making (SDM) are accumulating. This study aimed to not only identify physicians' perspectives on SDM, and practices related to end-of-life care in particular, but also to gauge the effect of SDM education on physicians in Korea.Entities:
Keywords: Clinical decision-making; End-of-life care; Life-sustaining treatment; Patient-centered care; Physician preference; Shared decision-making
Year: 2021 PMID: 34974652 PMCID: PMC8995478 DOI: 10.23876/j.krcp.21.071
Source DB: PubMed Journal: Kidney Res Clin Pract ISSN: 2211-9132
Demographics of the questionnaire respondents
| Variable | Overall | Educated | Non-educated | p-value |
|---|---|---|---|---|
| No. of respondents | 309 | 38 | 271 | |
| Sex | 0.12[ | |||
| Male | 174 (56.3) | 26 (68.4) | 148 (54.6) | |
| Female | 135 (43.7) | 12 (31.6) | 123 (45.4) | |
| Age (yr) | 0.11[ | |||
| <30 | 90 (29.1) | 14 (36.8) | 76 (28.0) | |
| 30–39 | 178 (57.6) | 22 (57.9) | 156 (57.6) | |
| 40–49 | 26 (8.4) | 1 (2.6) | 25 (9.2) | |
| 50–59 | 9 (2.9) | 1 (2.6) | 8 (3.0) | |
| 60–65 | 6 (1.9) | 0 (0) | 6 (2.2) | |
| Position | 0.41[ | |||
| Resident (1st/2nd grade) | 148 (47.9) | 16 (42.1) | 132 (48.7) | |
| Resident (3rd/4th grade) | 78 (25.2) | 15 (39.5) | 63 (23.2) | |
| Fellow | 32 (10.4) | 5 (13.2) | 27 (10.0) | |
| Professor | 51 (16.5) | 2 (5.3) | 49 (18.1) | |
| Position group | 0.047[ | |||
| Trainee | 258 (83.5) | 36 (94.7) | 222 (81.9) | |
| Nephrologist | 51 (16.5) | 2 (5.3) | 49 (18.1) | |
| No. of patients treated by respondent (/wk) | 0.54[ | |||
| <20 | 53 (17.2) | 7 (18.4) | 46 (17.0) | |
| 20–49 | 144 (46.6) | 20 (52.6) | 124 (45.8) | |
| 50–79 | 54 (17.5) | 5 (13.2) | 49 (18.1) | |
| 80–99 | 18 (5.8) | 1 (2.6) | 17 (6.3) | |
| ≥100 | 40 (12.9) | 5 (13.2) | 35 (12.9) | |
| No. of patients who made decisions[ | 0.48[ | |||
| <2 | 207 (67.0) | 28 (73.7) | 179 (66.1) | |
| 2–5 | 92 (29.8) | 9 (23.7) | 83 (30.6) | |
| 5–7 | 5 (1.6) | 0 (0) | 5 (1.8) | |
| 7–10 | 4 (1.3) | 1 (2.6) | 3 (1.1) | |
| ≥10 | 1 (0.3) | 0 (0) | 1 (0.4) |
Data are expressed as number only or number (%). Because of rounding, percentages might not sum to 100%.
The p-values obtained from
chi-square test or
linear-by-linear association test.
According to the Act on Decisions on Life-Sustaining Treatment for Patients in Hospice and Palliative Care or at the End-of-Life.
Figure 1.“Usual” decision-making approach of respondents after reading a fictional example of a patient in the decision-making process and detailed explanations of each decision-making approach.
(A) All respondents. (B) Educated group. (C) Non-educated group. SDM, shared decision-making.
Figure 2.Appropriateness of SDM in actual clinical practice and factors that hinder its proper application.
(A) Response to the question “Is SDM appropriately made in decision to withhold or withdraw of life-sustaining treatment in actual clinical practice?” (B) Patient aspects. (C) Medical system aspects. (D) Physician aspects.
SDM, shared decision-making.